Physician profile
Jaylon Garrett
NPI 1306470166
$1,739.57
in general payments reported to CMS, 2019-2025
16 companies · $451 in 2025
The $451 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $100 · 2022: $504 · 2023: $36.03 · 2024: $648 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,036 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,036.10 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $252.35 | 2023-2025 | |
| Ipsen Biopharmaceuticals, INC | $228.38 | 2024-2025 | Onivyde |
| Astrazeneca Pharmaceuticals LP | $214.93 | 2022 | |
| Janssen Biotech, INC. | $192.09 | 2022-2025 | Rybrevant, Carvykti |
| Takeda Pharmaceuticals U.S.A., INC. | $121.75 | 2024 | Ninlaro |
| Mirati Therapeutics, INC. | $119.60 | 2024 | Krazati |
| Myovant Sciences INC. | $112.77 | 2021-2022 | |
| Eli Lilly and Company | $109.30 | 2025 | |
| Exelixis INC. | $99.00 | 2024 | |
| Progenics Pharmaceuticals, INC. | $96.03 | 2022 | |
| Genzyme Corporation | $86.24 | 2022 | |
| Incyte Corporation | $28.27 | 2025 | Zynyz, Monjuvi |
| Novartis Pharmaceuticals Corporation | $23.87 | 2024 | |
| Astellas Pharma US INC | $22.68 | 2025 | Xtandi |
| Merck Sharp & Dohme LLC | $18.55 | 2025 | Welireg, Keytruda |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $13.76 | 2024 | Orgovyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaylon Garrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.